1. GD2-targeted immunotherapy and potential value of circulating microRNAs in neuroblastoma
   Sharareh Gholamin et al, 2018, J Cell Physiol CrossRef
2. The effect of dichloroacetate in canine prostate adenocarcinomas and transitional cell carcinomas in vitro
   Tatjana Harting et al, 2016 CrossRef
3. MiRNA Influences in Neuroblast Modulation: An Introspective Analysis
   Vanessa Zammit et al, 2018, Genes CrossRef
4. LncRNA XIST accelerates cervical cancer progression via upregulating Fus through competitively binding with miR-200a.
   Hong Zhu et al, 2018, Biomed Pharmacother CrossRef
5. null
   Duncan Ayers, 2019 CrossRef
6. FUS/circ_002136/miR-138-5p/SOX13 feedback loop regulates angiogenesis in Glioma
   Zhenwei He et al, 2019, J Exp Clin Cancer Res CrossRef
7. MicroRNA-141 enhances anoikis resistance in metastatic progression of ovarian cancer through targeting KLF12/Sp1/survivin axis
   Celia S. L. Mak et al, 2017, Mol Cancer CrossRef
8. Dichloroacetate affects proliferation but not apoptosis in canine mammary cell lines
   Tatjana P. Harting et al, 2017, PLoS ONE CrossRef
9. LncRNA SNHG15 contributes to proliferation, invasion and autophagy in osteosarcoma cells by sponging miR-141
   Ke Liu et al, 2017, J Biomed Sci CrossRef
10. Novel Function of lncRNA ADAMTS9-AS2 in Promoting Temozolomide Resistance in Glioblastoma via Upregulating the FUS/MDM2 Ubiquitination Axis
    Yuanliang Yan et al, 2019, Front. Cell Dev. Biol. CrossRef
11. Identification of Specific Long Non-Coding Ribonucleic Acid Signatures and Regulatory Networks in Prostate Cancer in Fine-Needle Aspiration Biopsies
    Zehuan Li et al, 2020, Front. Genet. CrossRef
12. Long noncoding RNA XXYLT1-AS2 regulates proliferation and adhesion by targeting the RNA binding protein FUS in HUVEC
    Qi Wang et al, 2020, Atherosclerosis CrossRef
13. Noncoding RNA in drug resistant sarcoma
    Xiaoyang Li et al, 2017, Oncotarget CrossRef
14. LncRNA HCG18 is critical for vascular smooth muscle cell proliferation and phenotypic switching
    Yanjiao Lu et al, 2020, Human Cell CrossRef
15. Interaction of BACH2 with FUS promotes malignant progression of glioma cells via the TSLNC8-miR-10b-5p-WWC3 pathway.
    Yang Yang et al, 2020, Mol Oncol CrossRef
16. miR-4478 sensitizes ovarian cancer cells to irradiation by inhibiting Fus and attenuating autophagy
    Lingling Wang et al, 2021, Molecular Therapy - Nucleic Acids CrossRef
17. Non-Coding RNAs Participate in the Pathogenesis of Neuroblastoma
    Omidvar Rezaei et al, 2021, Front. Oncol. CrossRef
18. Wild-Type and Mutant FUS Expression Reduce Proliferation and Neuronal Differentiation Properties of Neural Stem Progenitor Cells
    Eleonora Stronati et al, 2021, IJMS CrossRef
19. Long Non-coding RNA Rhabdomyosarcoma 2-Associated Transcript Regulates Angiogenesis in Endothelial Cells
    Maha Alaqeeli et al, 2021, Front. Physiol. CrossRef
20. MicroRNA as a Potential Therapeutic Molecule in Cancer
    Joanna Szczepanek et al, 2022, Cells CrossRef
21. The role of miR-200 family in the regulation of hallmarks of cancer
    Klaudia Klicka et al, 2022, Front. Oncol. CrossRef
22. MicroRNAs as prospective biomarkers, therapeutic targets and pharmaceuticals in neuroblastoma
    Natalia Andreeva et al, 2022, Mol Biol Rep CrossRef
23. Expression of IL-13Rα2 and FUS in glioma: clinicopathological and prognostic correlation
    Guang Cheng et al, 2023, BMC Neurol CrossRef
24. Role of non-coding RNAs in neuroblastoma
    Ali Arash Anoushirvani et al, 2023, Cancer Gene Ther CrossRef
25. Targeting NRAS via miR-1304-5p or farnesyltransferase inhibition confers sensitivity to ALK inhibitors in ALK-mutant neuroblastoma
    Perla Pucci et al, 2024, Nat Commun CrossRef